30 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... HF outcomes in HFrEF ... HF outcomes in HFrEF
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Stable Angina, HFpEF ... , HFrEF, AFib, TAA ... Dissection • CKD ... , DM, ESRD, PKD
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
• Oliguria Chronic ... ml/min per 1.73 m2 ... ml/min per 1.73 m2 ... /CKD • No structural ... damage #AKI #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
-4 inhibitors SGLT2 ... Improved outcomes in CKD ... endocrinology #dm2
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
and Titration Algorithm ... Established ASCVD or CKD ... established ASCVD or CKD ... #Diabetes #DM2 ... Medication #Management #Algorithm
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
drugs Other than SGLT2i ... metformin in T2D and CKD ... . chronic kidney ... receptor agonist SGLT2i ... , #KDIGO2020 #CKD
"Suggested management of chronic heart failure. Adapted from the 2016 European Society of Cardiology guidelines"-McMaster Textbook
management of chronic ... Pharmacotherapy of HFrEF ... CHF #Management #HFrEF ... #Cardiology #Algorithm
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
patients with Chronic ... CongestiveHeartFailure #Systolic #HFrEF ... #Algorithm #Management
Acute and Chronic Causes of Dyspnea - Differential Diagnosis
Pulmonary/Chest Wall:
 • Acute: Trauma, COPD exacerbation, Asthma
Acute and Chronic ... Hemorrhage • Chronic ... Pericarditis, CAD ... , HFrEF/HFpEF, Intracardiac ... acidosis (eg, DM
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... resynchronization therapy; DM ... heart failure; HFpEF ... ejection fraction; HFrEF ... Stages #ACCAHA #Algorithm